Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts

NCT: NCT07339306 · ACTIVE_NOT_RECRUITING

NCT IDNCT07339306
StatusACTIVE_NOT_RECRUITING
Start Date2026-01-01
Completion2026-12-30
SponsorThe Fourth Affiliated Hospital of China Medical University (OTHER)
First posted
Last updated

Brief Summary

This prospective, multicenter cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing a novel fluorescent localization needle equipped with a controllable shedding quantum dot chiral nanofluorescent coating, in contrast to traditional localization techniques for breast duct lesions. The principal objective is to assess the clinical efficacy of this innovative fluorescent localization needle in enabling precise pathological diagnosis of micro lesions in breast ducts.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑